Investing.com - Molecular Partners AG (NASDAQ: MOLN) reported fourth quarter EPS of $3.54, $4.20 better than the analyst estimate of $-0.66. Revenue for the quarter came in at $189.6M versus the consensus estimate of $4.52M.
Molecular Partners AG's stock price closed at $6.20. It is down -7.19% in the last 3 months and down -75.62% in the last 12 months.
Molecular Partners AG saw positive EPS revisions and negative EPS revisions in the last 90 days. See Molecular Partners AG's stock price’s past reactions to earnings here.
According to InvestingPro, Molecular Partners AG's Financial Health score is "excellent performance".
Check out Molecular Partners AG's recent earnings performance, and Molecular Partners AG's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar